Sinopharm

Sinopharm company information, Employees & Contact Information

Explore related pages

Related company profiles:

China National Pharmaceutical Group Corporation, SINOPHARM, is the largest pharmaceutical and healthcare group under State-Owned Assets Supervision and Administration Commission of the State Council (SASAC) in China, with core business of pharmaceutical distribution, scientific research and manufacture of medical and biotech products. The group has 16 wholly-owned subsidiaries and holding companies, one H-share listed company, Sinopharm Group Co., Ltd., and four A-share listed companies, China National Medicines Co., Ltd. (CNCM), Beijing Tiantan Biological Products Co., Ltd. (TiantanBio), Shyndec Pharmaceutical Co., Ltd. (Shyndec) and Shenzhen Accord Pharmaceutical Co., Ltd. (Accord). In 2009, the group’s revenue had reached 65 billion Yuan. Among the 129 central enterprises, SINOPHARM is ranked 50th and 38th in terms of revenue and total profit respectively. In 2010, SINOPHARM’s revenue is estimated to be 80 billion Yuan. SINOPHARM is the president unit of CPIA, CNNDA, CAPC, Sino-PhRDA, CAMDI, CATCM and CPCS etc., and also the sponsor and supporter of many important exhibitions including PHARMCHINA.

Company Details

Employees
716
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Looking for a particular Sinopharm employee's phone or email?

Sinopharm Questions

News

Development and characterization of the genotype F attenuated mumps candidate strains - Frontiers

Development and characterization of the genotype F attenuated mumps candidate strains Frontiers

tHIS ASEAN 2025 to Showcase Cutting-Edge Medical Technologies and Vast Market Potential of South Asia - PR Newswire

tHIS ASEAN 2025 to Showcase Cutting-Edge Medical Technologies and Vast Market Potential of South Asia PR Newswire

CMEF 2025: Promoting Holistic and High-Quality Development of Medical and Health Industry - PR Newswire UK

CMEF 2025: Promoting Holistic and High-Quality Development of Medical and Health Industry PR Newswire UK

The Sinopharm COVID-19 vaccine: What you need to know - World Health Organization (WHO)

The Sinopharm COVID-19 vaccine: What you need to know World Health Organization (WHO)

Longitudinal Analysis of Antibody Dynamics in Severe Fever with Thrombocytopenia Syndrome Patients — High-Incidence Regions of China, 2010–2023 - China CDC Weekly

Longitudinal Analysis of Antibody Dynamics in Severe Fever with Thrombocytopenia Syndrome Patients — High-Incidence Regions of China, 2010–2023 China CDC Weekly

Morocco’s Sothema to produce China’s Sinopharm vaccine - Reuters

Morocco’s Sothema to produce China’s Sinopharm vaccine Reuters

Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021 - Nature

Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021 Nature

Covid-19: China approves Sinopharm vaccine for general use - BBC

Covid-19: China approves Sinopharm vaccine for general use BBC

Observation of 4th-order water oxidation kinetics by time-resolved photovoltage spectroscopy - ScienceDirect.com

Observation of 4th-order water oxidation kinetics by time-resolved photovoltage spectroscopy ScienceDirect.com

tHIS ASEAN 2025 to Showcase Cutting-Edge Medical Technologies and Vast Market Potential of South Asia - ANTARA News

tHIS ASEAN 2025 to Showcase Cutting-Edge Medical Technologies and Vast Market Potential of South Asia ANTARA News

Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge - Frontiers

Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge Frontiers

WHO approves Sinopharm vaccine in potential boost to COVAX pipeline - Reuters

WHO approves Sinopharm vaccine in potential boost to COVAX pipeline Reuters

The 91st CMEF to Unveil Latest Trends in Medical Device Industry - ANTARA News

The 91st CMEF to Unveil Latest Trends in Medical Device Industry ANTARA News

Metagenomic next-generation sequencing-assisted diagnosis of a rare case of primary cutaneous acanthamoebiasis in an HIV patient: a case report - Frontiers

Metagenomic next-generation sequencing-assisted diagnosis of a rare case of primary cutaneous acanthamoebiasis in an HIV patient: a case report Frontiers

UAE launches COVID-19 vaccine production with China's Sinopharm - Reuters

UAE launches COVID-19 vaccine production with China's Sinopharm Reuters

Sinopharm COVID-19 booster weaker against Omicron - study - Reuters

Sinopharm COVID-19 booster weaker against Omicron - study Reuters

Opening the Door to the Chinese Pharmaceutical Market - BioProcess International

Opening the Door to the Chinese Pharmaceutical Market BioProcess International

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China - Frontiers

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China Frontiers

W.H.O. approves China’s Sinopharm vaccine for emergency use. (Published 2021) - The New York Times

W.H.O. approves China’s Sinopharm vaccine for emergency use. (Published 2021) The New York Times

China Approves Sinopharm's Covid-19 Vaccine as it Moves to Inoculate Millions - The New York Times

China Approves Sinopharm's Covid-19 Vaccine as it Moves to Inoculate Millions The New York Times

Iran receives China’s Sinopharm jabs as COVID deaths reach 60,000 - Al Jazeera

Iran receives China’s Sinopharm jabs as COVID deaths reach 60,000 Al Jazeera

Comparison of 1 Versus 2 Doses of Quadrivalent Influenza Vaccine in 3–8-Year-Old Children with Different Immunological States — Jiangsu Province, China, 2021 - China CDC Weekly

Comparison of 1 Versus 2 Doses of Quadrivalent Influenza Vaccine in 3–8-Year-Old Children with Different Immunological States — Jiangsu Province, China, 2021 China CDC Weekly

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial - The Lancet

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial The Lancet

How the Sinopharm Vaccine Works (Published 2022) - The New York Times

How the Sinopharm Vaccine Works (Published 2022) The New York Times

Citrine Medicine and Sinopharm Group Announce Strategic Partnership to Broaden and Accelerate Access to Rare Disease Drugs in China - PR Newswire

Citrine Medicine and Sinopharm Group Announce Strategic Partnership to Broaden and Accelerate Access to Rare Disease Drugs in China PR Newswire

Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system - BMC Infectious Diseases

Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system BMC Infectious Diseases

Merck inks deal with Sinopharm to commercialize COVID-19 pills in China - Fierce Pharma

Merck inks deal with Sinopharm to commercialize COVID-19 pills in China Fierce Pharma

Safety and immunogenicity of a broad-spectrum mosaic vaccine as a booster dose against SARS-CoV-2 Omicron and other circulating variants - medRxiv

Safety and immunogenicity of a broad-spectrum mosaic vaccine as a booster dose against SARS-CoV-2 Omicron and other circulating variants medRxiv

World’s Most Vaccinated Nation Is Spooked by Covid Spike (Published 2021) - The New York Times

World’s Most Vaccinated Nation Is Spooked by Covid Spike (Published 2021) The New York Times

A New Nano Adjuvant of PF3 Used for an Enhanced Hepatitis B Vaccine - Frontiers

A New Nano Adjuvant of PF3 Used for an Enhanced Hepatitis B Vaccine Frontiers

Coronavirus digest: Hungary to produce China's Sinopharm jab - DW

Coronavirus digest: Hungary to produce China's Sinopharm jab DW

Egypt to purchase 20 million doses of Sinopharm vaccine - Reuters

Egypt to purchase 20 million doses of Sinopharm vaccine Reuters

The four types of COVID-19 vaccine – a snapshot - Healthcare IT News

The four types of COVID-19 vaccine – a snapshot Healthcare IT News

Vaccine development for emerging infectious diseases - Nature

Vaccine development for emerging infectious diseases Nature

Chinese Covid-19 vaccine has 86% efficacy, UAE says - The Guardian

Chinese Covid-19 vaccine has 86% efficacy, UAE says The Guardian

Potent Anti-SARS-CoV-2 Efficacy of COVID-19 Hyperimmune Globulin from Vaccine-Immunized Plasma - Wiley

Potent Anti-SARS-CoV-2 Efficacy of COVID-19 Hyperimmune Globulin from Vaccine-Immunized Plasma Wiley

Real-time monitoring of the effectiveness of six COVID-19 vaccines in Hungary in 2021 using the screening method - medRxiv

Real-time monitoring of the effectiveness of six COVID-19 vaccines in Hungary in 2021 using the screening method medRxiv

Chinese vaccine safe for children as young as 3, says study - South China Morning Post

Chinese vaccine safe for children as young as 3, says study South China Morning Post

50 African Diplomats on Anti-Covid-19 Visit to China’s Sinopharm - africanews.com

50 African Diplomats on Anti-Covid-19 Visit to China’s Sinopharm africanews.com

Coronavirus (COVID-19) vaccine: Options, safety, and how to get it - Medical News Today

Coronavirus (COVID-19) vaccine: Options, safety, and how to get it Medical News Today

Zimbabwe Receives 200,000 Doses of Sinopharm Vaccine - africanews.com

Zimbabwe Receives 200,000 Doses of Sinopharm Vaccine africanews.com

Sinopharm jabs linked to 14 deaths - Nation Thailand

Sinopharm jabs linked to 14 deaths Nation Thailand

Sinopharm crosses 'critical threshold' on vaccines - China Daily

Sinopharm crosses 'critical threshold' on vaccines China Daily

Deyalsingh: Moonilal wrong on Sinopharm vaccine - Trinidad Express Newspapers

Deyalsingh: Moonilal wrong on Sinopharm vaccine Trinidad Express Newspapers

Sinopharm vaccine roll-out begins July 13 - nationnews.com

Sinopharm vaccine roll-out begins July 13 nationnews.com

Bajans urged to take Sinopharm - nationnews.com

Bajans urged to take Sinopharm nationnews.com

Sinopharm vaccinations pick up - nationnews.com

Sinopharm vaccinations pick up nationnews.com

‘We Have Full Trust In Sinopharm Vaccine’ – Chinese Ambassador - NewZimbabwe.com

‘We Have Full Trust In Sinopharm Vaccine’ – Chinese Ambassador NewZimbabwe.com

Top Sinopharm Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant